Synteract - About, Expertise, Therapeutic Specialties

About

Quick Links

Therapeutic Specialties

Synteract has broad therapeutic expertise in many areas.

Oncology
Cardiovascular
Anti-infective
Genitourinary
Immunology
Endocrinology
Respiratory
Dermatology

CNS
Ophthalmology
Gastroenterology
Hematology
Hepatic
Orthopedic
Nephrology

Specific areas of focus include Oncology, Cardiovascular,
CNS and Ophthalmology:

Oncology

Synteract’s oncology-focused teams have assisted clients with more than 160 oncology trials enrolling over 25,000 patients. Our in-depth therapeutic knowledge spans the entire clinical process, from the design and execution of proof of concept trials to regulatory approval. Our oncology Project Managers have an average of 9 years of oncology experience, our Medical Associates an average of 7, and our client medical advisor has over 17 years experience in all phases of oncology drug development, including large global, clinical programs and national regulatory authorities.

Cancer Specialties

Leukemia
AML
Brain metastases & Glioblastoma
Colorectal
Head and neck
Lung
Myeloma
Ovarian
Prostate

Breast
Bladder
Cervix
Lymphoma
Kaposi’s sarcoma
Melanoma
Renal cell
Pancreatic
Osteosarcoma

Drug Classes

Anti-angiogenics
Cytotoxics
Gene therapies
Monoclonal Antibodies

Anti-metastatics
Hormonal treatments
Growth factors
Vaccines

Central Nervous System

Synteract’s experienced project teams, therapeutic experts and access to top sites can help you develop the best strategies to conduct your CNS studies and navigate the regulatory process. Synteract has conducted studies in more than 9,000 subjects in the following indications:

Pain Studies

Acute and chronic pain
Migraine
Neuropathic pain
Postoperative pain

Dental pain
Musculoskeletal pain
Pain management

Psychiatric Indications

Attention deficit disorder
Sleep disorders

Compulsive gambling
Smoking cessation

Neurological indications

Amyotrophic lateral sclerosis
Erectile dysfunction
Parkinson’s disease

Alzheimer’s disease
Female sexual dysfunction

Cardiovascular

Synteract Cardiovascular focus stems from our roots in a cardiovascular-focused drug development company, where we conducted studies in over 7,000 patients with multiple products. Since that time, Synteract’s Cardiovascular teams have built on that base by conducting drug, diagnostic and device trials including an additional 8,000 subjects on many approved products.

Specialties

Thrombosis
Stroke
Valve replacement
Total heart replacement
Angina
Arrhythmia \ Atrial fibrillation
Diagnosis of CAD

CABG
Myocardial infarction
CHF
Hemostasis
Dyslipidemia
Intermittent claudication
Critical limb ischemia

Ophthalmology

Synteract has developed a specialized clinical operations and therapeutic focus on ophthalmology studies with experienced project teams dedicated to all ophthalmic programs. Our experienced staff has conducted studies on more than 7,000 patients in a wide variety of specialties: